Cencora, Inc. (BIT:1COR)

Market Cap	58.85B +24.1%
Revenue (ttm)	277.46B +7.4%
Net Income	1.38B +16.4%
EPS	7.10 +18.6%
Shares Out	n/a
PE Ratio	42.51
Forward PE	20.02
Dividend	1.56 (0.53%)
Ex-Dividend Date	Nov 13, 2025

Volume	n/a
Average Volume	2
Open	n/a
Previous Close	301.16
Day's Range	n/a
52-Week Range	237.46 - 330.95
Beta	n/a
RSI	54.73
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1COR

Financial Performance

In fiscal year 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD